Nautilus Biotechnology, Inc.

NAUTNASDAQHealthcare● Active

$2.34

$-0.05(-2.20%)

Market Cap$297046824

P/E Ratio—

52W High$4.31

52W Low$0.62

Avg Volume373K

Open$2.45

Beta0.75

Forecast Market Cap PE Ratio

Nautilus Biotechnology, Inc.（NAUT）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

naut · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

Buy

5 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 5 · 买入占比: 60.0%

12 个月目标价

High

$2.50

Consensus

$2.50

+7.1% upside

Low

$2.50

Median: $2.5 · Last Close: $2.33

Nautilus Biotechnology, Inc.（NAUT）的分析师共识为 Buy，基于过去 3 个月内 5 位华尔街分析师的评级。NAUT 的 12 个月平均目标价为 $2.50，相对当前价 $2.33 代表 +7.1% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$2.29	↓ 1.79%	$2.27	$2.32

1-day model range: $2.27–$2.32. Peak: $2.32 (-1.79%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$1	$1	$2	-37.9%
2028	$1	$1	$1	-49.7%
2029	$1	$1	$1	-54.5%
2030	$1	$1	$1	-56.6%
2031	$1	—	$1	-57.6%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%

2Buy

1Neutral

11Sell

RSI (14)49.0Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NAUT · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$2.53SELL

MA 10$2.58SELL

MA 20$2.60SELL

MA 50$2.83SELL

MA 100$2.65SELL

MA 200$2.03BUY

Current $NAUT · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$2.49SELL

EMA 10$2.54SELL

EMA 20$2.60SELL

EMA 50$2.68SELL

EMA 100$2.56SELL

EMA 200$2.23BUY

Current $NAUT · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-02-27	Guggenheim	Maintains	Buy→Buy
2024-12-05	Goldman Sachs	Downgrade ↓	Neutral→Sell
2023-08-03	Morgan Stanley	Maintains	Equal Weight→Equal Weight
2022-08-03	Goldman Sachs	Maintains	Neutral→Neutral
2022-08-03	Morgan Stanley	Maintains	Equal Weight→Equal Weight
2022-07-14	Goldman Sachs	Maintains	Neutral→Neutral
2022-04-13	Goldman Sachs	Maintains	Neutral→Neutral
2022-01-06	Morgan Stanley	Maintains	Equal Weight→Equal Weight
2021-11-02	Cowen & Co.	Maintains	Outperform→Outperform
2021-08-04	Goldman Sachs	Maintains	Neutral→Neutral

Guggenheim2026-02-27

Maintains

Buy→Buy

Goldman Sachs2024-12-05

Downgrade ↓

Neutral→Sell

Morgan Stanley2023-08-03

Maintains

Equal Weight→Equal Weight

Goldman Sachs2022-08-03

Maintains

Neutral→Neutral

Morgan Stanley2022-08-03

Maintains

Equal Weight→Equal Weight

Goldman Sachs2022-07-14

Maintains

Neutral→Neutral

Goldman Sachs2022-04-13

Maintains

Neutral→Neutral

Morgan Stanley2022-01-06

Maintains

Equal Weight→Equal Weight

Cowen & Co.2021-11-02

Maintains

Outperform→Outperform

Goldman Sachs2021-08-04

Maintains

Neutral→Neutral

Wall Street analysts have recently issued updated ratings on Nautilus Biotechnology, Inc. (NAUT) stock. Of the recent 11 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover NAUT.

分析师推荐趋势

Buy ratings0 → 1↑ +1

Hold ratings1 → 0↓ 1

Sell ratings0 → 0

NAUT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$1M

↓ 97.7% YoY

Revenue Next Year

$8M

↑ 992.9% YoY

EPS This Year

$-0.52

EPS Next Year

$-0.52

↑ 1.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NAUT EPS of $-0.52 for the current fiscal year, based on estimates from 2 analysts. The NAUT revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

NAUT 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NAUT 的共识目标价为 $2.50（+7.1% 上行空间），分析师共识为 Buy。

NAUT 的短期预测（明日）为 $2.29（-1.79%）。 NAUT 对 2027 年的股价预测均值为 $1。 NAUT 对 2030 年的预测区间为 $1–$1。

Nautilus Biotechnology, Inc. 在 NASDAQ 上市，代码 NAUT。NAUT 在 2027 年的整体展望偏积极，在覆盖分析师中约 60% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

NAUT 预测 · 8 个问题

根据 5 位华尔街分析师，NAUT 的 12 个月平均目标价为 $2.50，最高 $2.50、最低 $2.50。若有图表，中位目标价可在上方查看。相对当前价 $2.33，隐含约 +7.1% 的上行空间。

NAUT 目标价NAUT 分析师目标价NAUT 12个月目标价目标价 NAUT

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.